Global Medical Marijuana Market Growth 2025-2031
The global Medical Marijuana market size is predicted to grow from US$ 7245 million in 2025 to US$ 27170 million in 2031; it is expected to grow at a CAGR of 24.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Medical Marijuana Industry Forecast” looks at past sales and reviews total world Medical Marijuana sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Marijuana sales for 2025 through 2031. With Medical Marijuana sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Marijuana industry.
This Insight Report provides a comprehensive analysis of the global Medical Marijuana landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Marijuana portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Marijuana market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Marijuana and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Marijuana.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Marijuana market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Marijuana market?
What factors are driving Medical Marijuana market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Marijuana market opportunities vary by end market size?
How does Medical Marijuana break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Medical Marijuana Industry Forecast” looks at past sales and reviews total world Medical Marijuana sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Marijuana sales for 2025 through 2031. With Medical Marijuana sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Marijuana industry.
This Insight Report provides a comprehensive analysis of the global Medical Marijuana landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Marijuana portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Marijuana market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Marijuana and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Marijuana.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Marijuana market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Dried Flower
- Oils + Concentrates
- Softgel Capsules
- Muscle Spasms
- Nausea (from cancer chemotherapy)
- Chronic Illness (HIV/Nerve Pain)
- Seizure Disorders
- Crohn's Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Scotts Miracle-Gro
- Canopy Growth
- GW Pharmaceuticals
- Aurora Cannabis
- Aphria
- MedReLeaf
- Insys Therapeutics
- Sprott
- CanniMed Therapeutics
- Horizons Marijuana Life Sciences Index ETF
What is the 10-year outlook for the global Medical Marijuana market?
What factors are driving Medical Marijuana market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Marijuana market opportunities vary by end market size?
How does Medical Marijuana break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Renal Cell Cacinoma Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Renal Cell Cacinoma Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Renal Cell Cacinoma Drugs by Country/Region, 2020, 2024 & 2031
2.2 Renal Cell Cacinoma Drugs Segment by Type
2.2.1 Sutent(Sunitinib)
2.2.2 Nexavar(Sorafenib)
2.2.3 Votrient(Pazopanib)
2.2.4 Avastin(Bevacizumab)
2.2.5 Afinitor(Everolimus)
2.2.6 Inlyta(Axitinib)
2.2.7 Torisel(Temsirolimus)
2.2.8 Proleukin(Aldesleukin)
2.3 Renal Cell Cacinoma Drugs Sales by Type
2.3.1 Global Renal Cell Cacinoma Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Renal Cell Cacinoma Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Renal Cell Cacinoma Drugs Sale Price by Type (2020-2025)
2.4 Renal Cell Cacinoma Drugs Segment by Application
2.4.1 Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
2.4.2 Multilocular Cystic Clear Cell Renal Cell Carcinoma
2.4.3 Tubulocystic Renal Cell Carcinoma
2.4.4 Thyroid-Like Follicular Renal Cell Carcinoma
2.4.5 Others
2.5 Renal Cell Cacinoma Drugs Sales by Application
2.5.1 Global Renal Cell Cacinoma Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Renal Cell Cacinoma Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Renal Cell Cacinoma Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Renal Cell Cacinoma Drugs Breakdown Data by Company
3.1.1 Global Renal Cell Cacinoma Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Renal Cell Cacinoma Drugs Sales Market Share by Company (2020-2025)
3.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Renal Cell Cacinoma Drugs Revenue by Company (2020-2025)
3.2.2 Global Renal Cell Cacinoma Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Renal Cell Cacinoma Drugs Sale Price by Company
3.4 Key Manufacturers Renal Cell Cacinoma Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Renal Cell Cacinoma Drugs Product Location Distribution
3.4.2 Players Renal Cell Cacinoma Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RENAL CELL CACINOMA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Renal Cell Cacinoma Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Renal Cell Cacinoma Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Renal Cell Cacinoma Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Renal Cell Cacinoma Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Renal Cell Cacinoma Drugs Sales Growth
4.4 APAC Renal Cell Cacinoma Drugs Sales Growth
4.5 Europe Renal Cell Cacinoma Drugs Sales Growth
4.6 Middle East & Africa Renal Cell Cacinoma Drugs Sales Growth
5 AMERICAS
5.1 Americas Renal Cell Cacinoma Drugs Sales by Country
5.1.1 Americas Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
5.1.2 Americas Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
5.2 Americas Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
5.3 Americas Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Renal Cell Cacinoma Drugs Sales by Region
6.1.1 APAC Renal Cell Cacinoma Drugs Sales by Region (2020-2025)
6.1.2 APAC Renal Cell Cacinoma Drugs Revenue by Region (2020-2025)
6.2 APAC Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
6.3 APAC Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Renal Cell Cacinoma Drugs by Country
7.1.1 Europe Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
7.1.2 Europe Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
7.2 Europe Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
7.3 Europe Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Renal Cell Cacinoma Drugs by Country
8.1.1 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Renal Cell Cacinoma Drugs
10.3 Manufacturing Process Analysis of Renal Cell Cacinoma Drugs
10.4 Industry Chain Structure of Renal Cell Cacinoma Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Renal Cell Cacinoma Drugs Distributors
11.3 Renal Cell Cacinoma Drugs Customer
12 WORLD FORECAST REVIEW FOR RENAL CELL CACINOMA DRUGS BY GEOGRAPHIC REGION
12.1 Global Renal Cell Cacinoma Drugs Market Size Forecast by Region
12.1.1 Global Renal Cell Cacinoma Drugs Forecast by Region (2026-2031)
12.1.2 Global Renal Cell Cacinoma Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Renal Cell Cacinoma Drugs Forecast by Type (2026-2031)
12.7 Global Renal Cell Cacinoma Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co., Inc.
13.1.1 Merck & Co., Inc. Company Information
13.1.2 Merck & Co., Inc. Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.1.3 Merck & Co., Inc. Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co., Inc. Main Business Overview
13.1.5 Merck & Co., Inc. Latest Developments
13.2 Exelixis Inc
13.2.1 Exelixis Inc Company Information
13.2.2 Exelixis Inc Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.2.3 Exelixis Inc Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Exelixis Inc Main Business Overview
13.2.5 Exelixis Inc Latest Developments
13.3 Argus Therapeutics, Inc.
13.3.1 Argus Therapeutics, Inc. Company Information
13.3.2 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.3.3 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Argus Therapeutics, Inc. Main Business Overview
13.3.5 Argus Therapeutics, Inc. Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Genentech
13.5.1 Genentech Company Information
13.5.2 Genentech Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.5.3 Genentech Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Genentech Main Business Overview
13.5.5 Genentech Latest Developments
13.6 Immatics Biotechnologies
13.6.1 Immatics Biotechnologies Company Information
13.6.2 Immatics Biotechnologies Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.6.3 Immatics Biotechnologies Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Immatics Biotechnologies Main Business Overview
13.6.5 Immatics Biotechnologies Latest Developments
13.7 AVEO Oncology
13.7.1 AVEO Oncology Company Information
13.7.2 AVEO Oncology Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.7.3 AVEO Oncology Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AVEO Oncology Main Business Overview
13.7.5 AVEO Oncology Latest Developments
13.8 Eisai
13.8.1 Eisai Company Information
13.8.2 Eisai Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.8.3 Eisai Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eisai Main Business Overview
13.8.5 Eisai Latest Developments
13.9 Acceleron
13.9.1 Acceleron Company Information
13.9.2 Acceleron Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.9.3 Acceleron Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Acceleron Main Business Overview
13.9.5 Acceleron Latest Developments
13.10 Rexahn Pharmaceuticals
13.10.1 Rexahn Pharmaceuticals Company Information
13.10.2 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.10.3 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Rexahn Pharmaceuticals Main Business Overview
13.10.5 Rexahn Pharmaceuticals Latest Developments
13.11 Bionomics
13.11.1 Bionomics Company Information
13.11.2 Bionomics Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.11.3 Bionomics Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bionomics Main Business Overview
13.11.5 Bionomics Latest Developments
13.12 Cerulean Pharma Inc
13.12.1 Cerulean Pharma Inc Company Information
13.12.2 Cerulean Pharma Inc Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.12.3 Cerulean Pharma Inc Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cerulean Pharma Inc Main Business Overview
13.12.5 Cerulean Pharma Inc Latest Developments
13.13 Celldex Therapeutics
13.13.1 Celldex Therapeutics Company Information
13.13.2 Celldex Therapeutics Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.13.3 Celldex Therapeutics Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Celldex Therapeutics Main Business Overview
13.13.5 Celldex Therapeutics Latest Developments
13.14 TVAX Biomedical
13.14.1 TVAX Biomedical Company Information
13.14.2 TVAX Biomedical Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.14.3 TVAX Biomedical Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 TVAX Biomedical Main Business Overview
13.14.5 TVAX Biomedical Latest Developments
13.15 TRACON Pharmaceuticals
13.15.1 TRACON Pharmaceuticals Company Information
13.15.2 TRACON Pharmaceuticals Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.15.3 TRACON Pharmaceuticals Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 TRACON Pharmaceuticals Main Business Overview
13.15.5 TRACON Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Renal Cell Cacinoma Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Renal Cell Cacinoma Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Renal Cell Cacinoma Drugs by Country/Region, 2020, 2024 & 2031
2.2 Renal Cell Cacinoma Drugs Segment by Type
2.2.1 Sutent(Sunitinib)
2.2.2 Nexavar(Sorafenib)
2.2.3 Votrient(Pazopanib)
2.2.4 Avastin(Bevacizumab)
2.2.5 Afinitor(Everolimus)
2.2.6 Inlyta(Axitinib)
2.2.7 Torisel(Temsirolimus)
2.2.8 Proleukin(Aldesleukin)
2.3 Renal Cell Cacinoma Drugs Sales by Type
2.3.1 Global Renal Cell Cacinoma Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Renal Cell Cacinoma Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Renal Cell Cacinoma Drugs Sale Price by Type (2020-2025)
2.4 Renal Cell Cacinoma Drugs Segment by Application
2.4.1 Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
2.4.2 Multilocular Cystic Clear Cell Renal Cell Carcinoma
2.4.3 Tubulocystic Renal Cell Carcinoma
2.4.4 Thyroid-Like Follicular Renal Cell Carcinoma
2.4.5 Others
2.5 Renal Cell Cacinoma Drugs Sales by Application
2.5.1 Global Renal Cell Cacinoma Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Renal Cell Cacinoma Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Renal Cell Cacinoma Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Renal Cell Cacinoma Drugs Breakdown Data by Company
3.1.1 Global Renal Cell Cacinoma Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Renal Cell Cacinoma Drugs Sales Market Share by Company (2020-2025)
3.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Renal Cell Cacinoma Drugs Revenue by Company (2020-2025)
3.2.2 Global Renal Cell Cacinoma Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Renal Cell Cacinoma Drugs Sale Price by Company
3.4 Key Manufacturers Renal Cell Cacinoma Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Renal Cell Cacinoma Drugs Product Location Distribution
3.4.2 Players Renal Cell Cacinoma Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RENAL CELL CACINOMA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Renal Cell Cacinoma Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Renal Cell Cacinoma Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Renal Cell Cacinoma Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Renal Cell Cacinoma Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Renal Cell Cacinoma Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Renal Cell Cacinoma Drugs Sales Growth
4.4 APAC Renal Cell Cacinoma Drugs Sales Growth
4.5 Europe Renal Cell Cacinoma Drugs Sales Growth
4.6 Middle East & Africa Renal Cell Cacinoma Drugs Sales Growth
5 AMERICAS
5.1 Americas Renal Cell Cacinoma Drugs Sales by Country
5.1.1 Americas Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
5.1.2 Americas Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
5.2 Americas Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
5.3 Americas Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Renal Cell Cacinoma Drugs Sales by Region
6.1.1 APAC Renal Cell Cacinoma Drugs Sales by Region (2020-2025)
6.1.2 APAC Renal Cell Cacinoma Drugs Revenue by Region (2020-2025)
6.2 APAC Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
6.3 APAC Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Renal Cell Cacinoma Drugs by Country
7.1.1 Europe Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
7.1.2 Europe Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
7.2 Europe Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
7.3 Europe Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Renal Cell Cacinoma Drugs by Country
8.1.1 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Renal Cell Cacinoma Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Renal Cell Cacinoma Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Renal Cell Cacinoma Drugs
10.3 Manufacturing Process Analysis of Renal Cell Cacinoma Drugs
10.4 Industry Chain Structure of Renal Cell Cacinoma Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Renal Cell Cacinoma Drugs Distributors
11.3 Renal Cell Cacinoma Drugs Customer
12 WORLD FORECAST REVIEW FOR RENAL CELL CACINOMA DRUGS BY GEOGRAPHIC REGION
12.1 Global Renal Cell Cacinoma Drugs Market Size Forecast by Region
12.1.1 Global Renal Cell Cacinoma Drugs Forecast by Region (2026-2031)
12.1.2 Global Renal Cell Cacinoma Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Renal Cell Cacinoma Drugs Forecast by Type (2026-2031)
12.7 Global Renal Cell Cacinoma Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co., Inc.
13.1.1 Merck & Co., Inc. Company Information
13.1.2 Merck & Co., Inc. Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.1.3 Merck & Co., Inc. Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co., Inc. Main Business Overview
13.1.5 Merck & Co., Inc. Latest Developments
13.2 Exelixis Inc
13.2.1 Exelixis Inc Company Information
13.2.2 Exelixis Inc Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.2.3 Exelixis Inc Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Exelixis Inc Main Business Overview
13.2.5 Exelixis Inc Latest Developments
13.3 Argus Therapeutics, Inc.
13.3.1 Argus Therapeutics, Inc. Company Information
13.3.2 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.3.3 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Argus Therapeutics, Inc. Main Business Overview
13.3.5 Argus Therapeutics, Inc. Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Genentech
13.5.1 Genentech Company Information
13.5.2 Genentech Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.5.3 Genentech Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Genentech Main Business Overview
13.5.5 Genentech Latest Developments
13.6 Immatics Biotechnologies
13.6.1 Immatics Biotechnologies Company Information
13.6.2 Immatics Biotechnologies Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.6.3 Immatics Biotechnologies Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Immatics Biotechnologies Main Business Overview
13.6.5 Immatics Biotechnologies Latest Developments
13.7 AVEO Oncology
13.7.1 AVEO Oncology Company Information
13.7.2 AVEO Oncology Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.7.3 AVEO Oncology Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AVEO Oncology Main Business Overview
13.7.5 AVEO Oncology Latest Developments
13.8 Eisai
13.8.1 Eisai Company Information
13.8.2 Eisai Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.8.3 Eisai Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eisai Main Business Overview
13.8.5 Eisai Latest Developments
13.9 Acceleron
13.9.1 Acceleron Company Information
13.9.2 Acceleron Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.9.3 Acceleron Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Acceleron Main Business Overview
13.9.5 Acceleron Latest Developments
13.10 Rexahn Pharmaceuticals
13.10.1 Rexahn Pharmaceuticals Company Information
13.10.2 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.10.3 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Rexahn Pharmaceuticals Main Business Overview
13.10.5 Rexahn Pharmaceuticals Latest Developments
13.11 Bionomics
13.11.1 Bionomics Company Information
13.11.2 Bionomics Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.11.3 Bionomics Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bionomics Main Business Overview
13.11.5 Bionomics Latest Developments
13.12 Cerulean Pharma Inc
13.12.1 Cerulean Pharma Inc Company Information
13.12.2 Cerulean Pharma Inc Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.12.3 Cerulean Pharma Inc Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cerulean Pharma Inc Main Business Overview
13.12.5 Cerulean Pharma Inc Latest Developments
13.13 Celldex Therapeutics
13.13.1 Celldex Therapeutics Company Information
13.13.2 Celldex Therapeutics Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.13.3 Celldex Therapeutics Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Celldex Therapeutics Main Business Overview
13.13.5 Celldex Therapeutics Latest Developments
13.14 TVAX Biomedical
13.14.1 TVAX Biomedical Company Information
13.14.2 TVAX Biomedical Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.14.3 TVAX Biomedical Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 TVAX Biomedical Main Business Overview
13.14.5 TVAX Biomedical Latest Developments
13.15 TRACON Pharmaceuticals
13.15.1 TRACON Pharmaceuticals Company Information
13.15.2 TRACON Pharmaceuticals Renal Cell Cacinoma Drugs Product Portfolios and Specifications
13.15.3 TRACON Pharmaceuticals Renal Cell Cacinoma Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 TRACON Pharmaceuticals Main Business Overview
13.15.5 TRACON Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Marijuana Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Medical Marijuana Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dried Flower
Table 4. Major Players of Oils + Concentrates
Table 5. Major Players of Softgel Capsules
Table 6. Global Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 7. Global Medical Marijuana Sales Market Share by Type (2020-2025)
Table 8. Global Medical Marijuana Revenue by Type (2020-2025) & ($ million)
Table 9. Global Medical Marijuana Revenue Market Share by Type (2020-2025)
Table 10. Global Medical Marijuana Sale Price by Type (2020-2025) & (USD/MT)
Table 11. Global Medical Marijuana Sale by Application (2020-2025) & (K MT)
Table 12. Global Medical Marijuana Sale Market Share by Application (2020-2025)
Table 13. Global Medical Marijuana Revenue by Application (2020-2025) & ($ million)
Table 14. Global Medical Marijuana Revenue Market Share by Application (2020-2025)
Table 15. Global Medical Marijuana Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Medical Marijuana Sales by Company (2020-2025) & (K MT)
Table 17. Global Medical Marijuana Sales Market Share by Company (2020-2025)
Table 18. Global Medical Marijuana Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Medical Marijuana Revenue Market Share by Company (2020-2025)
Table 20. Global Medical Marijuana Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Medical Marijuana Producing Area Distribution and Sales Area
Table 22. Players Medical Marijuana Products Offered
Table 23. Medical Marijuana Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Medical Marijuana Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Medical Marijuana Sales Market Share Geographic Region (2020-2025)
Table 28. Global Medical Marijuana Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Medical Marijuana Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Medical Marijuana Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Medical Marijuana Sales Market Share by Country/Region (2020-2025)
Table 32. Global Medical Marijuana Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Medical Marijuana Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 35. Americas Medical Marijuana Sales Market Share by Country (2020-2025)
Table 36. Americas Medical Marijuana Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 38. Americas Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 39. APAC Medical Marijuana Sales by Region (2020-2025) & (K MT)
Table 40. APAC Medical Marijuana Sales Market Share by Region (2020-2025)
Table 41. APAC Medical Marijuana Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 43. APAC Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 44. Europe Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 45. Europe Medical Marijuana Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 47. Europe Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Medical Marijuana Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 51. Middle East & Africa Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Medical Marijuana
Table 53. Key Market Challenges & Risks of Medical Marijuana
Table 54. Key Industry Trends of Medical Marijuana
Table 55. Medical Marijuana Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Medical Marijuana Distributors List
Table 58. Medical Marijuana Customer List
Table 59. Global Medical Marijuana Sales Forecast by Region (2026-2031) & (K MT)
Table 60. Global Medical Marijuana Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 62. Americas Medical Marijuana Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Medical Marijuana Sales Forecast by Region (2026-2031) & (K MT)
Table 64. APAC Medical Marijuana Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 66. Europe Medical Marijuana Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Medical Marijuana Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Medical Marijuana Sales Forecast by Type (2026-2031) & (K MT)
Table 70. Global Medical Marijuana Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Medical Marijuana Sales Forecast by Application (2026-2031) & (K MT)
Table 72. Global Medical Marijuana Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Scotts Miracle-Gro Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 74. Scotts Miracle-Gro Medical Marijuana Product Portfolios and Specifications
Table 75. Scotts Miracle-Gro Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Scotts Miracle-Gro Main Business
Table 77. Scotts Miracle-Gro Latest Developments
Table 78. Canopy Growth Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 79. Canopy Growth Medical Marijuana Product Portfolios and Specifications
Table 80. Canopy Growth Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Canopy Growth Main Business
Table 82. Canopy Growth Latest Developments
Table 83. GW Pharmaceuticals Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 84. GW Pharmaceuticals Medical Marijuana Product Portfolios and Specifications
Table 85. GW Pharmaceuticals Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. GW Pharmaceuticals Main Business
Table 87. GW Pharmaceuticals Latest Developments
Table 88. Aurora Cannabis Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 89. Aurora Cannabis Medical Marijuana Product Portfolios and Specifications
Table 90. Aurora Cannabis Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Aurora Cannabis Main Business
Table 92. Aurora Cannabis Latest Developments
Table 93. Aphria Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 94. Aphria Medical Marijuana Product Portfolios and Specifications
Table 95. Aphria Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Aphria Main Business
Table 97. Aphria Latest Developments
Table 98. MedReLeaf Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 99. MedReLeaf Medical Marijuana Product Portfolios and Specifications
Table 100. MedReLeaf Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. MedReLeaf Main Business
Table 102. MedReLeaf Latest Developments
Table 103. Insys Therapeutics Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 104. Insys Therapeutics Medical Marijuana Product Portfolios and Specifications
Table 105. Insys Therapeutics Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Insys Therapeutics Main Business
Table 107. Insys Therapeutics Latest Developments
Table 108. Sprott Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 109. Sprott Medical Marijuana Product Portfolios and Specifications
Table 110. Sprott Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Sprott Main Business
Table 112. Sprott Latest Developments
Table 113. CanniMed Therapeutics Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 114. CanniMed Therapeutics Medical Marijuana Product Portfolios and Specifications
Table 115. CanniMed Therapeutics Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. CanniMed Therapeutics Main Business
Table 117. CanniMed Therapeutics Latest Developments
Table 118. Horizons Marijuana Life Sciences Index ETF Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 119. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Product Portfolios and Specifications
Table 120. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Horizons Marijuana Life Sciences Index ETF Main Business
Table 122. Horizons Marijuana Life Sciences Index ETF Latest Developments
Table 1. Medical Marijuana Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Medical Marijuana Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dried Flower
Table 4. Major Players of Oils + Concentrates
Table 5. Major Players of Softgel Capsules
Table 6. Global Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 7. Global Medical Marijuana Sales Market Share by Type (2020-2025)
Table 8. Global Medical Marijuana Revenue by Type (2020-2025) & ($ million)
Table 9. Global Medical Marijuana Revenue Market Share by Type (2020-2025)
Table 10. Global Medical Marijuana Sale Price by Type (2020-2025) & (USD/MT)
Table 11. Global Medical Marijuana Sale by Application (2020-2025) & (K MT)
Table 12. Global Medical Marijuana Sale Market Share by Application (2020-2025)
Table 13. Global Medical Marijuana Revenue by Application (2020-2025) & ($ million)
Table 14. Global Medical Marijuana Revenue Market Share by Application (2020-2025)
Table 15. Global Medical Marijuana Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Medical Marijuana Sales by Company (2020-2025) & (K MT)
Table 17. Global Medical Marijuana Sales Market Share by Company (2020-2025)
Table 18. Global Medical Marijuana Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Medical Marijuana Revenue Market Share by Company (2020-2025)
Table 20. Global Medical Marijuana Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Medical Marijuana Producing Area Distribution and Sales Area
Table 22. Players Medical Marijuana Products Offered
Table 23. Medical Marijuana Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Medical Marijuana Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Medical Marijuana Sales Market Share Geographic Region (2020-2025)
Table 28. Global Medical Marijuana Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Medical Marijuana Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Medical Marijuana Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Medical Marijuana Sales Market Share by Country/Region (2020-2025)
Table 32. Global Medical Marijuana Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Medical Marijuana Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 35. Americas Medical Marijuana Sales Market Share by Country (2020-2025)
Table 36. Americas Medical Marijuana Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 38. Americas Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 39. APAC Medical Marijuana Sales by Region (2020-2025) & (K MT)
Table 40. APAC Medical Marijuana Sales Market Share by Region (2020-2025)
Table 41. APAC Medical Marijuana Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 43. APAC Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 44. Europe Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 45. Europe Medical Marijuana Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 47. Europe Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Medical Marijuana Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Medical Marijuana Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Medical Marijuana Sales by Type (2020-2025) & (K MT)
Table 51. Middle East & Africa Medical Marijuana Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Medical Marijuana
Table 53. Key Market Challenges & Risks of Medical Marijuana
Table 54. Key Industry Trends of Medical Marijuana
Table 55. Medical Marijuana Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Medical Marijuana Distributors List
Table 58. Medical Marijuana Customer List
Table 59. Global Medical Marijuana Sales Forecast by Region (2026-2031) & (K MT)
Table 60. Global Medical Marijuana Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 62. Americas Medical Marijuana Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Medical Marijuana Sales Forecast by Region (2026-2031) & (K MT)
Table 64. APAC Medical Marijuana Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 66. Europe Medical Marijuana Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Medical Marijuana Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Medical Marijuana Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Medical Marijuana Sales Forecast by Type (2026-2031) & (K MT)
Table 70. Global Medical Marijuana Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Medical Marijuana Sales Forecast by Application (2026-2031) & (K MT)
Table 72. Global Medical Marijuana Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Scotts Miracle-Gro Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 74. Scotts Miracle-Gro Medical Marijuana Product Portfolios and Specifications
Table 75. Scotts Miracle-Gro Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Scotts Miracle-Gro Main Business
Table 77. Scotts Miracle-Gro Latest Developments
Table 78. Canopy Growth Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 79. Canopy Growth Medical Marijuana Product Portfolios and Specifications
Table 80. Canopy Growth Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Canopy Growth Main Business
Table 82. Canopy Growth Latest Developments
Table 83. GW Pharmaceuticals Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 84. GW Pharmaceuticals Medical Marijuana Product Portfolios and Specifications
Table 85. GW Pharmaceuticals Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. GW Pharmaceuticals Main Business
Table 87. GW Pharmaceuticals Latest Developments
Table 88. Aurora Cannabis Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 89. Aurora Cannabis Medical Marijuana Product Portfolios and Specifications
Table 90. Aurora Cannabis Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Aurora Cannabis Main Business
Table 92. Aurora Cannabis Latest Developments
Table 93. Aphria Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 94. Aphria Medical Marijuana Product Portfolios and Specifications
Table 95. Aphria Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Aphria Main Business
Table 97. Aphria Latest Developments
Table 98. MedReLeaf Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 99. MedReLeaf Medical Marijuana Product Portfolios and Specifications
Table 100. MedReLeaf Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. MedReLeaf Main Business
Table 102. MedReLeaf Latest Developments
Table 103. Insys Therapeutics Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 104. Insys Therapeutics Medical Marijuana Product Portfolios and Specifications
Table 105. Insys Therapeutics Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Insys Therapeutics Main Business
Table 107. Insys Therapeutics Latest Developments
Table 108. Sprott Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 109. Sprott Medical Marijuana Product Portfolios and Specifications
Table 110. Sprott Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Sprott Main Business
Table 112. Sprott Latest Developments
Table 113. CanniMed Therapeutics Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 114. CanniMed Therapeutics Medical Marijuana Product Portfolios and Specifications
Table 115. CanniMed Therapeutics Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. CanniMed Therapeutics Main Business
Table 117. CanniMed Therapeutics Latest Developments
Table 118. Horizons Marijuana Life Sciences Index ETF Basic Information, Medical Marijuana Manufacturing Base, Sales Area and Its Competitors
Table 119. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Product Portfolios and Specifications
Table 120. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Horizons Marijuana Life Sciences Index ETF Main Business
Table 122. Horizons Marijuana Life Sciences Index ETF Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Marijuana
Figure 2. Medical Marijuana Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Marijuana Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Medical Marijuana Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Medical Marijuana Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Medical Marijuana Sales Market Share by Country/Region (2024)
Figure 10. Medical Marijuana Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dried Flower
Figure 12. Product Picture of Oils + Concentrates
Figure 13. Product Picture of Softgel Capsules
Figure 14. Global Medical Marijuana Sales Market Share by Type in 2025
Figure 15. Global Medical Marijuana Revenue Market Share by Type (2020-2025)
Figure 16. Medical Marijuana Consumed in Muscle Spasms
Figure 17. Global Medical Marijuana Market: Muscle Spasms (2020-2025) & (K MT)
Figure 18. Medical Marijuana Consumed in Nausea (from cancer chemotherapy)
Figure 19. Global Medical Marijuana Market: Nausea (from cancer chemotherapy) (2020-2025) & (K MT)
Figure 20. Medical Marijuana Consumed in Chronic Illness (HIV/Nerve Pain)
Figure 21. Global Medical Marijuana Market: Chronic Illness (HIV/Nerve Pain) (2020-2025) & (K MT)
Figure 22. Medical Marijuana Consumed in Seizure Disorders
Figure 23. Global Medical Marijuana Market: Seizure Disorders (2020-2025) & (K MT)
Figure 24. Medical Marijuana Consumed in Crohn's Disease
Figure 25. Global Medical Marijuana Market: Crohn's Disease (2020-2025) & (K MT)
Figure 26. Global Medical Marijuana Sale Market Share by Application (2024)
Figure 27. Global Medical Marijuana Revenue Market Share by Application in 2025
Figure 28. Medical Marijuana Sales by Company in 2025 (K MT)
Figure 29. Global Medical Marijuana Sales Market Share by Company in 2025
Figure 30. Medical Marijuana Revenue by Company in 2025 ($ millions)
Figure 31. Global Medical Marijuana Revenue Market Share by Company in 2025
Figure 32. Global Medical Marijuana Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Medical Marijuana Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Medical Marijuana Sales 2020-2025 (K MT)
Figure 35. Americas Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 36. APAC Medical Marijuana Sales 2020-2025 (K MT)
Figure 37. APAC Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 38. Europe Medical Marijuana Sales 2020-2025 (K MT)
Figure 39. Europe Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Medical Marijuana Sales 2020-2025 (K MT)
Figure 41. Middle East & Africa Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 42. Americas Medical Marijuana Sales Market Share by Country in 2025
Figure 43. Americas Medical Marijuana Revenue Market Share by Country (2020-2025)
Figure 44. Americas Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 45. Americas Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 46. United States Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Medical Marijuana Sales Market Share by Region in 2025
Figure 51. APAC Medical Marijuana Revenue Market Share by Region (2020-2025)
Figure 52. APAC Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 53. APAC Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 54. China Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 58. India Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Medical Marijuana Sales Market Share by Country in 2025
Figure 62. Europe Medical Marijuana Revenue Market Share by Country (2020-2025)
Figure 63. Europe Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 64. Europe Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 65. Germany Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 66. France Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Medical Marijuana Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 73. Egypt Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Medical Marijuana in 2025
Figure 79. Manufacturing Process Analysis of Medical Marijuana
Figure 80. Industry Chain Structure of Medical Marijuana
Figure 81. Channels of Distribution
Figure 82. Global Medical Marijuana Sales Market Forecast by Region (2026-2031)
Figure 83. Global Medical Marijuana Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Medical Marijuana Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Medical Marijuana Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Medical Marijuana Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Medical Marijuana Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Medical Marijuana
Figure 2. Medical Marijuana Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Marijuana Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Medical Marijuana Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Medical Marijuana Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Medical Marijuana Sales Market Share by Country/Region (2024)
Figure 10. Medical Marijuana Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dried Flower
Figure 12. Product Picture of Oils + Concentrates
Figure 13. Product Picture of Softgel Capsules
Figure 14. Global Medical Marijuana Sales Market Share by Type in 2025
Figure 15. Global Medical Marijuana Revenue Market Share by Type (2020-2025)
Figure 16. Medical Marijuana Consumed in Muscle Spasms
Figure 17. Global Medical Marijuana Market: Muscle Spasms (2020-2025) & (K MT)
Figure 18. Medical Marijuana Consumed in Nausea (from cancer chemotherapy)
Figure 19. Global Medical Marijuana Market: Nausea (from cancer chemotherapy) (2020-2025) & (K MT)
Figure 20. Medical Marijuana Consumed in Chronic Illness (HIV/Nerve Pain)
Figure 21. Global Medical Marijuana Market: Chronic Illness (HIV/Nerve Pain) (2020-2025) & (K MT)
Figure 22. Medical Marijuana Consumed in Seizure Disorders
Figure 23. Global Medical Marijuana Market: Seizure Disorders (2020-2025) & (K MT)
Figure 24. Medical Marijuana Consumed in Crohn's Disease
Figure 25. Global Medical Marijuana Market: Crohn's Disease (2020-2025) & (K MT)
Figure 26. Global Medical Marijuana Sale Market Share by Application (2024)
Figure 27. Global Medical Marijuana Revenue Market Share by Application in 2025
Figure 28. Medical Marijuana Sales by Company in 2025 (K MT)
Figure 29. Global Medical Marijuana Sales Market Share by Company in 2025
Figure 30. Medical Marijuana Revenue by Company in 2025 ($ millions)
Figure 31. Global Medical Marijuana Revenue Market Share by Company in 2025
Figure 32. Global Medical Marijuana Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Medical Marijuana Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Medical Marijuana Sales 2020-2025 (K MT)
Figure 35. Americas Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 36. APAC Medical Marijuana Sales 2020-2025 (K MT)
Figure 37. APAC Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 38. Europe Medical Marijuana Sales 2020-2025 (K MT)
Figure 39. Europe Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Medical Marijuana Sales 2020-2025 (K MT)
Figure 41. Middle East & Africa Medical Marijuana Revenue 2020-2025 ($ millions)
Figure 42. Americas Medical Marijuana Sales Market Share by Country in 2025
Figure 43. Americas Medical Marijuana Revenue Market Share by Country (2020-2025)
Figure 44. Americas Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 45. Americas Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 46. United States Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Medical Marijuana Sales Market Share by Region in 2025
Figure 51. APAC Medical Marijuana Revenue Market Share by Region (2020-2025)
Figure 52. APAC Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 53. APAC Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 54. China Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 58. India Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Medical Marijuana Sales Market Share by Country in 2025
Figure 62. Europe Medical Marijuana Revenue Market Share by Country (2020-2025)
Figure 63. Europe Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 64. Europe Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 65. Germany Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 66. France Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Medical Marijuana Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Medical Marijuana Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Medical Marijuana Sales Market Share by Application (2020-2025)
Figure 73. Egypt Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Medical Marijuana Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Medical Marijuana in 2025
Figure 79. Manufacturing Process Analysis of Medical Marijuana
Figure 80. Industry Chain Structure of Medical Marijuana
Figure 81. Channels of Distribution
Figure 82. Global Medical Marijuana Sales Market Forecast by Region (2026-2031)
Figure 83. Global Medical Marijuana Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Medical Marijuana Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Medical Marijuana Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Medical Marijuana Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Medical Marijuana Revenue Market Share Forecast by Application (2026-2031)
